Biotech | October 29, 2021
Takeda to acquire GammaDelta Therapeutics
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
